NUCB2 and gastric ulcer: Kolgazi et al. (2017) have demonstrated that blockade of selective COX-1 or COX-2 enzymes or non-selective COX-inhibitor indomethacin, reversed most of the therapeutic effects of nesfatin-1 peptide on acetic acid-induced gastric ulcer, while COX-2-blockade was consistently more effective.